Fundz

Fundz Deep Dive

Everything you need to win Molecular Partners AG — in one platform.

Who to reach, what to say, and why now on Molecular Partners AG — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Molecular Partners AG — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Molecular Partners and Orano Med Strengthen Co-Development Agreement for Radio-DARPin Therapeutics

Oct 22, 2024over 1 year ago

Contract Type

agreement

BiotechnologyTherapeuticsBiopharma

Description

Molecular Partners AG and Orano Med have strengthened their co-development agreement to include the co-development and commercialization of four Radio-DARPin programs. Each company will have the right to commercialize two of the programs, and Molecular Partners will hold commercial rights to the second nominated Radio-DARPin Candidate. The collaboration aims to develop and market Pb-based Radio-DARPin Therapeutics for the treatment of cancer.

Company Information

Company

Molecular Partners AG

About

Molecular Partners AG is a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics.

Predictive Intelligence
Strategic

ML-powered predictions for Molecular Partners AG's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.